DJ 53
Latest Information Update: 18 Apr 2002
At a glance
- Originator Nonindustrial sources
- Class Antineoplastics; Stilbenes
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 18 Apr 2002 No development reported - Preclinical for Breast cancer in USA (unspecified route)
- 28 Feb 2000 New profile
- 28 Feb 2000 Preclinical development for Breast cancer in USA (Unknown route)